Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction
This study is currently recruiting participants.
Study NCT00378352 Information provided by National Institute on Aging (NIA)
First Received: September 18, 2006 Last Updated: December 2, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Infarction
Myocardial Infarction
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Ischemia
Myocardial Ischemia
Necrosis
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Erythropoietin (Epoetin alfa)
Placebo
Additional drug interventions recognized in this trial
Epoetin Alfa
More general drug interventions related to this trial
Hematinics
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute on Aging (NIA)
Back to top of Main Content